Casdin Capital as of Dec. 31, 2018
Portfolio Holdings for Casdin Capital
Casdin Capital holds 31 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Loxo Oncology | 8.6 | $50M | 360k | 140.07 | |
| Myokardia | 6.6 | $39M | 790k | 48.86 | |
| Blueprint Medicines (BPMC) | 5.9 | $35M | 640k | 53.91 | |
| Codexis (CDXS) | 5.8 | $34M | 2.0M | 16.70 | |
| Spark Therapeutics | 5.6 | $33M | 840k | 39.14 | |
| Bluebird Bio (BLUE) | 5.6 | $33M | 330k | 99.20 | |
| Fate Therapeutics (FATE) | 5.6 | $33M | 2.6M | 12.83 | |
| Sage Therapeutics (SAGE) | 5.1 | $30M | 312k | 95.79 | |
| Biolife Solutions (BLFS) | 5.0 | $29M | 2.4M | 12.03 | |
| Invitae (NVTAQ) | 4.5 | $27M | 2.4M | 11.06 | |
| Alnylam Pharmaceuticals (ALNY) | 4.4 | $26M | 355k | 72.91 | |
| Agios Pharmaceuticals (AGIO) | 3.5 | $21M | 445k | 46.11 | |
| GenMark Diagnostics | 3.2 | $19M | 3.8M | 4.86 | |
| Audentes Therapeutics | 3.1 | $18M | 860k | 21.32 | |
| Illumina (ILMN) | 3.1 | $18M | 60k | 299.93 | |
| Sarepta Therapeutics (SRPT) | 2.8 | $16M | 150k | 109.13 | |
| Magenta Therapeutics | 2.6 | $15M | 2.6M | 5.70 | |
| Global Blood Therapeutics In | 2.5 | $14M | 350k | 41.05 | |
| Sangamo Biosciences (SGMO) | 2.1 | $12M | 1.1M | 11.48 | |
| Gritstone Oncology Ord (GRTSQ) | 1.9 | $11M | 721k | 15.45 | |
| Evolent Health (EVH) | 1.9 | $11M | 550k | 19.95 | |
| Editas Medicine (EDIT) | 1.9 | $11M | 480k | 22.75 | |
| Voyager Therapeutics (VYGR) | 1.8 | $11M | 1.1M | 9.40 | |
| Beigene | 1.7 | $9.8M | 70k | 140.26 | |
| Homology Medicines | 1.3 | $7.8M | 350k | 22.36 | |
| Constellation Pharmceticls I | 1.1 | $6.2M | 1.6M | 4.01 | |
| iShares NASDAQ Biotechnology Index (IBB) | 1.0 | $5.8M | 60k | 96.43 | |
| Caredx (CDNA) | 0.9 | $5.0M | 200k | 25.14 | |
| Denali Therapeutics (DNLI) | 0.3 | $2.1M | 100k | 20.66 | |
| Quotient | 0.3 | $2.0M | 325k | 6.12 | |
| Neon Therapeutics | 0.2 | $1.3M | 263k | 5.03 |
